[1] 中华医学会传染病与寄生虫病学分会和肝病学分会. 病毒性肝炎防治方案[J]．中华肝脏病杂志，2000，8（6）：324-329．
[2] VELDT BJ，HEATHCOTE EJ，WEDEMEYER H，et al.Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and dvanced fibrosis[J]. Ann Intern Med，2007，147:677-684.
[3] GUPTA R，RAMAKRISHNA CH，LAKHTAKIA S，et al.Efficacy of low dose peginterferon alpha-2b with ribavirin on chronic hepatitis C[J]. World J Gastroenterol，2006，12:5554-5556.
[4] KAMAL SM，KAMARY SS，SHARDELL MD，et al. Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C:The role of rapid and early virologic response[J]. Hepatology，2007，46:1732-1740.
[5] MARCO V，ALMASIO PL，FERRARO D，et al. Peginterferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial[J]. Hepatology，2007，47:484-491. |
